Kendrick Charles Morgan JR
Officer at ELV
- Sold, on record
- $10.9M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Mar 6, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ELVElevance Health, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice ELVNoticeMar 8, 2024 2024
Filed to sell 2,432 shares ($1.2M)
Kendrick Charles Morgan JR, Officer
No 10b5-1 planFiling
- 2 Form 4 sale ELVNo planMar 8, 2024 same day
Sold 2,432 shares at $500.46 ($1.2M)
Kendrick Charles Morgan JR, EVP & President, Commercial
No 10b5-1 planSold 13.3% of holdings ($9.1M position)15,840 shares leftFollows a Form 144Filing
- 3 Form 144 notice ELVNoticeOct 18, 2024 +224 days
Filed to sell 7,417 shares ($3.2M)
Kendrick Charles Morgan JR, Director
No 10b5-1 planFiling
- 4 Form 4 sale ELVUnusualOct 18, 2024 same day
Sold 7,417 shares at $432.14 ($3.2M)
Kendrick Charles Morgan JR, EVP & President, Commercial
No 10b5-1 planSold 46.8% of holdings ($6.8M position)8,423 shares leftFollows a Form 144Filing
- 5 Form 4 sale ELVUnusualMar 5, 2025 +138 days
Sold 3,504 shares at $396.30 ($1.4M)
Kendrick Charles Morgan JR, EVP & President, Commercial
No 10b5-1 planSold 25.7% of holdings ($5.4M position)10,116 shares left1.4x usual sizeFollows a Form 144Filing
- 6 Form 144 notice ELVNoticeMar 5, 2025 same day
Filed to sell 3,504 shares ($1.4M)
Kendrick Charles Morgan JR, Officer
No 10b5-1 plan1.4x usual sizeFiling
- 7 Form 144 notice ELVNoticeMar 6, 2026 +366 days
Filed to sell 3,196 shares ($911k)
Kendrick Charles Morgan JR, Officer
No 10b5-1 plan0.9x usual sizeFiling
- 8 Form 4 sale ELVNo planMar 6, 2026 same day
Sold 3,196 shares at $284.92 ($911k)
Kendrick Charles Morgan JR, EVP & President, Commercial
No 10b5-1 planSold 21.3% of holdings ($4.3M position)11,791 shares left0.9x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Mar 9, 2026 | ELV | EVP & President, Commercial | Form 4 sale | 3,196 | $911k | 21.3% | No plan | SEC |
| Mar 6, 2026 | Mar 6, 2026 | ELV | Officer | Form 144 notice | 3,196 | $911k | Notice | SEC | |
| Mar 5, 2025 | Mar 5, 2025 | ELV | Officer | Form 144 notice | 3,504 | $1.4M | Notice | SEC | |
| Mar 5, 2025 | Mar 5, 2025 | ELV | EVP & President, Commercial | Form 4 sale | 3,504 | $1.4M | 25.7% | Unusual | SEC |
| Oct 18, 2024 | Oct 18, 2024 | ELV | EVP & President, Commercial | Form 4 sale | 7,417 | $3.2M | 46.8% | Unusual | SEC |
| Oct 18, 2024 | Oct 18, 2024 | ELV | Director | Form 144 notice | 7,417 | $3.2M | Notice | SEC | |
| Mar 8, 2024 | Mar 12, 2024 | ELV | EVP & President, Commercial | Form 4 sale | 2,432 | $1.2M | 13.3% | No plan | SEC |
| Mar 8, 2024 | Mar 8, 2024 | ELV | Officer | Form 144 notice | 2,432 | $1.2M | Notice | SEC | |
| Mar 9, 2023 | Mar 13, 2023 | ELV | EVP & President, Commercial | Form 4 sale | 2,314 | $1.1M | 13.1% | Plan not stated | SEC |
| Jun 9, 2022 | Jun 13, 2022 | ELV | EVP & President, Commercial | Form 4 sale | 6,328 | $3.1M | 30.3% | Unusual | SEC |